| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vertex Pharmaceuticals Incorporated (VRTX) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 43 sells. VRTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 133.5K | $60.29M | - | |
| COO | 63.4K | $28.62M | - | |
| VP | 51.1K | $23.07M | - | |
| VP | 42.3K | $19.10M | - | |
| Other | 24.0K | $10.85M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 5, 2021 | Sanna Bastiano | EVP, Cell &Genetic Therapies | Sell | 1,686 | $214.14 | $361,046.44 | -2.3% | -7.1% | +25.4% | |
| Mar 5, 2021 | Liu Joy | SVP, General Counsel | Sell | 5,141 | $209.69 | $1,078,017.59 | -7.8% | -0.4% | +12.6% | |
| Mar 1, 2021 | Silva Paul M | SVP &Chief Accounting Officer | Sell | 2,782 | $211.45 | $588,255.25 | -6.1% | -0.3% | +9.7% | |
| Feb 25, 2021 | Silva Paul M | SVP &Chief Accounting Officer | Sell | 1,080 | $213.47 | $230,551.50 | -1.7% | -2.9% | +8.1% | |
| Feb 25, 2021 | Arbuckle Stuart A | EVP, Chief Commercial Officer | Sell | 3,634 | $213.54 | $775,988.98 | -1.4% | -2.9% | +8.1% | |
| Feb 25, 2021 | Altshuler David48 | EVP, Global Research And CSO | Sell | 3,028 | $213.39 | $646,138.52 | -2.1% | -2.9% | +8.1% | |
| Feb 25, 2021 | Sachdev Amit | EVP, Chief Patient Officer | Sell | 3,586 | $213.42 | $765,307.40 | -1.7% | -2.9% | +8.1% | |
| Feb 25, 2021 | Parini Michael | EVP, Chief Adm, Leg &Bd Off | Sell | 3,028 | $213.38 | $646,125.04 | -2.3% | -2.9% | +8.1% | |
| Feb 18, 2021 | Parini Michael | EVP, Chief Adm, Leg &Bd Off | Sell | 7,825 | $211.83 | $1,657,556.46 | -4.8% | +2.0% | +9.4% | |
| Feb 18, 2021 | Arbuckle Stuart A | EVP, Chief Commercial Officer | Sell | 7,825 | $211.82 | $1,657,480.77 | -3.8% | +2.0% | +9.4% |